Dept. of Control Engineering and Information Technology, Budapest University of Technology and Economics, Magyar Tudósok krt. 2, H-1117 Budapest, Hungary.
Comput Methods Programs Biomed. 2011 May;102(2):105-18. doi: 10.1016/j.cmpb.2010.06.019. Epub 2010 Jul 31.
Using induced L₂-norm minimization, a robust controller was developed for insulin delivery in Type I diabetic patients. The high-complexity nonlinear diabetic patient Sorensen-model was considered and Linear Parameter Varying methodology was used to develop open-loop model and robust H(∞) controller. Considering the normoglycaemic set point (81.1 mg/dL), a polytopic set was created over the physiologic boundaries of the glucose-insulin interaction of the Sorensen-model. In this way, Linear Parameter Varying model formalism was defined. The robust control was developed considering input and output multiplicative uncertainties with two additional uncertainties from those used in the literature: sensor noise and worst-case design for meal disturbance (60 g carbohydrate). Simulation scenario on large meal absorption illustrates the applicability of the robust LPV control technique, while patient variability is tested with real data taken from the SPRINT clinical protocol on ICU patients.
使用诱导 L₂-范数最小化,为 I 型糖尿病患者的胰岛素输送开发了一种鲁棒控制器。考虑了高复杂度的非线性糖尿病患者 Sorensen 模型,并使用线性参数变化方法来开发开环模型和鲁棒 H(∞)控制器。考虑到正常血糖设定点(81.1mg/dL),在 Sorensen 模型的葡萄糖-胰岛素相互作用的生理边界上创建了一个多面体集。通过这种方式,定义了线性参数变化模型形式。考虑到输入和输出的乘性不确定性,并考虑了文献中使用的另外两个不确定性:传感器噪声和最坏情况下的餐食干扰设计(60g 碳水化合物),对大餐吸收进行了仿真场景,说明了鲁棒 LPV 控制技术的适用性,同时使用 ICU 患者 SPRINT 临床方案中采集的真实数据对患者变异性进行了测试。